{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:42:59Z","timestamp":1791434579461,"version":"4.3.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T00:00:00Z","timestamp":1546473600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007172","name":"Cincinnati Children's Hospital Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s40262-018-0729-3","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T22:57:20Z","timestamp":1546469840000},"page":"793-803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8471-9826","authenticated-orcid":false,"given":"Tomoyuki","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja M.","family":"Gist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Wempe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Alten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Vinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,3]]},"reference":[{"issue":"1","key":"729_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.jvca.2016.05.029","volume":"31","author":"VV Lomivorotov","year":"2017","unstructured":"Lomivorotov VV, Efremov SM, Kirov MY, Fominskiy EV, Karaskov AM. Low-cardiac-output syndrome after cardiac surgery. J Cardiothorac Vasc Anesth. 2017;31(1):291\u2013308.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"7","key":"729_CR2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/01.CIR.0000051365.81920.28","volume":"107","author":"TM Hoffman","year":"2003","unstructured":"Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003;107(7):996\u20131002.","journal-title":"Circulation"},{"issue":"2","key":"729_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/FJC.0000000000000327","volume":"67","author":"KM Gist","year":"2016","unstructured":"Gist KM, Goldstein SL, Joy MS, Vinks AA. Milrinone dosing issues in critically ill children with kidney injury: a review. J Cardiovasc Pharmacol. 2016;67(2):175\u201381.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"6","key":"729_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1097\/FTD.0000000000000214","volume":"37","author":"KM Gist","year":"2015","unstructured":"Gist KM, Mizuno T, Goldstein SL, Vinks A. Retrospective evaluation of milrinone pharmacokinetics in children with kidney injury. Ther Drug Monit. 2015;37(6):792\u20136.","journal-title":"Ther Drug Monit"},{"issue":"8","key":"729_CR5","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s001340051322","volume":"26","author":"T Taniguchi","year":"2000","unstructured":"Taniguchi T, Shibata K, Saito S, Matsumoto H, Okeie K. Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration. Intensive Care Med. 2000;26(8):1089\u201393.","journal-title":"Intensive Care Med"},{"issue":"5","key":"729_CR6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/BF00635891","volume":"29","author":"R Larsson","year":"1986","unstructured":"Larsson R, Liedholm H, Andersson KE, Keane MA, Henry G. Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment. Eur J Clin Pharmacol. 1986;29(5):549\u201353.","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"729_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1074248413489773","volume":"18","author":"ZL Cox","year":"2013","unstructured":"Cox ZL, Calcutt MW, Morrison TB, Akers WS, Davis MB, Lenihan DJ. Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction. J Cardiovasc Pharmacol Ther. 2013;18(5):433\u20138.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"729_CR8","first-page":"420","volume":"63","author":"T Bishara","year":"2010","unstructured":"Bishara T, Seto WT, Trope A, Parshuram CS. Use of milrinone in critically ill children. Can J Hosp Pharm. 2010;63(6):420\u20138.","journal-title":"Can J Hosp Pharm"},{"issue":"3","key":"729_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/00000542-199409000-00014","volume":"81","author":"JM Bailey","year":"1994","unstructured":"Bailey JM, Levy JH, Kikura M, Szlam F, Hug CC Jr. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology. 1994;81(3):616\u201322.","journal-title":"Anesthesiology"},{"issue":"3","key":"729_CR10","doi-asserted-by":"publisher","first-page":"F204","DOI":"10.1136\/adc.2005.092817","volume":"92","author":"M Paradisis","year":"2007","unstructured":"Paradisis M, Jiang X, McLachlan AJ, Evans N, Kluckow M, Osborn D. Population pharmacokinetics and dosing regimen design of milrinone in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2007;92(3):F204\u20139.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"729_CR11","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1213\/01.ane.0000198626.67391.34","volume":"102","author":"AF Zuppa","year":"2006","unstructured":"Zuppa AF, Nicolson SC, Adamson PC, Wernovsky G, Mondick JT, Burnham N, et al. Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction. Anesth Analg. 2006;102(4):1062\u20139.","journal-title":"Anesth Analg"},{"issue":"4","key":"729_CR12","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/00000542-199904000-00014","volume":"90","author":"JM Bailey","year":"1999","unstructured":"Bailey JM, Miller BE, Lu W, Tosone SR, Kanter KR, Tam VK. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology. 1999;90(4):1012\u20138.","journal-title":"Anesthesiology"},{"issue":"4","key":"729_CR13","first-page":"783","volume":"81","author":"JFt Butterworth","year":"1995","unstructured":"Butterworth JFt, Hines RL, Royster RL, James RL. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg. 1995;81(4):783\u201392.","journal-title":"Anesth Analg"},{"issue":"2","key":"729_CR14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1213\/00000539-199802000-00011","volume":"86","author":"C Ramamoorthy","year":"1998","unstructured":"Ramamoorthy C, Anderson GD, Williams GD, Lynn AM. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg. 1998;86(2):283\u20139.","journal-title":"Anesth Analg"},{"issue":"1","key":"729_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/B:JOPA.0000029488.45177.48","volume":"31","author":"JM Bailey","year":"2004","unstructured":"Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC, et al. A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn. 2004;31(1):43\u201359.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"12","key":"729_CR16","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157\u201367.","journal-title":"N Engl J Med"},{"issue":"2","key":"729_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/FTD.0000000000000496","volume":"40","author":"KM Gist","year":"2018","unstructured":"Gist KM, Cooper DS, Wrona J, Faubel S, Altmann C, Gao Z, et al. Acute kidney injury biomarkers predict an increase in serum milrinone concentration earlier than serum creatinine-defined acute kidney injury in infants after cardiac surgery. Ther Drug Monit. 2018;40(2):186\u201394.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"729_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit\u2014a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79(3):241\u201357.","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"729_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2133\/dmpk.24.25","volume":"24","author":"BJ Anderson","year":"2009","unstructured":"Anderson BJ, Holford NH. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet. 2009;24(1):25\u201336.","journal-title":"Drug Metab Pharmacokinet"},{"key":"729_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","volume":"48","author":"BJ Anderson","year":"2008","unstructured":"Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol. 2008;48:303\u201332.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"729_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/j.1552-4604.1997.tb04326.x","volume":"37","author":"EI Ette","year":"1997","unstructured":"Ette EI. Stability and performance of a population pharmacokinetic model. J Clin Pharmacol. 1997;37(6):486\u201395.","journal-title":"J Clin Pharmacol"},{"key":"729_CR22","unstructured":"Holford N. The visual predictive check - superiority to standard diagnostic (Rorschach) plots [abstract no. 738]. Annual meeting of the population approach group in Europe (PAGE); 16\u201317 Jun 2005; Pamplona."},{"key":"729_CR23","unstructured":"National Health and Nutrition Examination Survey. Questionnaires, datasets, and related documentation. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/Default.aspx . Accessed 10 Dec 2018."},{"issue":"6","key":"729_CR24","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/clpt.2009.199","volume":"86","author":"MS Mouksassi","year":"2009","unstructured":"Mouksassi MS, Marier JF, Cyran J, Vinks AA. Clinical trial simulations in pediatric patients using realistic covariates: application to teduglutide, a glucagon-like peptide-2 analog in neonates and infants with short-bowel syndrome. Clin Pharmacol Ther. 2009;86(6):667\u201371.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"729_CR25","doi-asserted-by":"publisher","first-page":"e26470","DOI":"10.1002\/pbc.26470","volume":"64","author":"T Mizuno","year":"2017","unstructured":"Mizuno T, Fukuda T, Emoto C, Mobberley-Schuman PS, Hammill AM, Adams DM, et al. Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies. Pediatr Blood Cancer. 2017;64(8):e26470.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"729_CR26","first-page":"16","volume":"85","author":"M Kikura","year":"1997","unstructured":"Kikura M, Levy JH, Michelsen LG, Shanewise JS, Bailey JM, Sadel SM, et al. The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesth Analg. 1997;85(1):16\u201322.","journal-title":"Anesth Analg"},{"issue":"4","key":"729_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40262-014-0134-5","volume":"53","author":"I Mahmood","year":"2014","unstructured":"Mahmood I. Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings. Clin Pharmacokinet. 2014;53(4):327\u201346.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"729_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/cpt.169","volume":"98","author":"AA Vinks","year":"2015","unstructured":"Vinks AA, Emoto C, Fukuda T. Modeling and simulation in pediatric drug therapy: application of pharmacometrics to define the right dose for children. Clin Pharmacol Ther. 2015;98(3):298\u2013308.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"729_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/archdischild-2013-303720","volume":"98","author":"BJ Anderson","year":"2013","unstructured":"Anderson BJ, Holford NH. Understanding dosing: children are small adults, neonates are immature children. Arch Dis Child. 2013;98(9):737\u201344.","journal-title":"Arch Dis Child."},{"issue":"1","key":"729_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00467-008-0997-5","volume":"24","author":"MM Rhodin","year":"2009","unstructured":"Rhodin MM, Anderson BJ, Peters AM, Coulthard MG, Wilkins B, Cole M, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24(1):67\u201376.","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"729_CR31","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1460-9592.2011.03536.x","volume":"21","author":"BJ Anderson","year":"2011","unstructured":"Anderson BJ, Holford NH. Tips and traps analyzing pediatric PK data. Paediatr Anaesth. 2011;21(3):222\u201337.","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"729_CR32","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/adc.2009.177592","volume":"95","author":"P Patel","year":"2010","unstructured":"Patel P, Mulla H, Tanna S, Pandya H. Facilitating pharmacokinetic studies in children: a new use of dried blood spots. Arch Dis Child. 2010;95(6):484\u20137.","journal-title":"Arch Dis Child"},{"issue":"6","key":"729_CR33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jpeds.2015.08.032","volume":"167","author":"JR Wiles","year":"2015","unstructured":"Wiles JR, Isemann B, Mizuno T, Tabangin ME, Ward LP, Akinbi H, et al. Pharmacokinetics of oral methadone in the treatment of neonatal abstinence syndrome: a pilot study. J Pediatr. 2015;167(6):1214\u20131220 e3.","journal-title":"J Pediatr"},{"issue":"3","key":"729_CR34","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1365-2125.2012.04392.x","volume":"75","author":"P Patel","year":"2013","unstructured":"Patel P, Mulla H, Kairamkonda V, Spooner N, Gade S, Della Pasqua O, et al. Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants. Br J Clin Pharmacol. 2013;75(3):805\u201313.","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"729_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1055\/s-0036-1597996","volume":"34","author":"A Giaccone","year":"2017","unstructured":"Giaccone A, Zuppa AF, Sood B, Cohen MS, O\u2019Byrne ML, Moorthy G, et al. Milrinone Pharmacokinetics and pharmacodynamics in neonates with persistent pulmonary hypertension of the newborn. Am J Perinatol. 2017;34(8):749\u201358.","journal-title":"Am J Perinatol"},{"issue":"1","key":"729_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000447049","volume":"111","author":"M Hallik","year":"2017","unstructured":"Hallik M, Tasa T, Starkopf J, Metsvaht T. Dosing of milrinone in preterm neonates to prevent postligation cardiac syndrome: simulation study suggests need for bolus infusion. Neonatology. 2017;111(1):8\u201311.","journal-title":"Neonatology"},{"issue":"5","key":"729_CR37","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/bmc.1675","volume":"26","author":"B Chihoho","year":"2012","unstructured":"Chihoho B, Sage AB, Smolenski RT, Vazir A, Rose ML, Banner NR, et al. A clinical assay for the measurement of milrinone in plasma by HPLC mass spectrometry. Biomed Chromatogr. 2012;26(5):566\u201370.","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"729_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/FTD.0000000000000072","volume":"36","author":"P Gavra","year":"2014","unstructured":"Gavra P, Nguyen AQ, Theoret Y, Litalien C, Denault AY, Varin F. A specific and sensitive HPLC\u2013MS\/MS micromethod for milrinone plasma levels determination after inhalation in cardiac patients. Ther Drug Monit. 2014;36(5):663\u20138.","journal-title":"Ther Drug Monit"},{"issue":"8","key":"729_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/psp4.12096","volume":"5","author":"C Emoto","year":"2016","unstructured":"Emoto C, Fukuda T, Mizuno T, Schniedewind B, Christians U, Adams DM, et al. Characterizing the developmental trajectory of sirolimus clearance in neonates and infants. CPT Pharmacomet Syst Pharmacol. 2016;5(8):411\u20137.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"729_CR40","unstructured":"Children\u2019s Hospital Medical Center, Cincinnati. Milrinone pharmacokinetics and acute kidney injury (MIL-PK) [ClinicalTrials.gov identifier NCT01966237]. US National Institutes of Health, ClinicalTrials.gov. https:\/\/www.clinicaltrials.gov . Accessed 7 Dec 2018."}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-018-0729-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-018-0729-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-018-0729-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T12:24:08Z","timestamp":1662726248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-018-0729-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,3]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1007\/s40262-018-0729-3","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,3]]},"assertion":[{"value":"3 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The original prospective study (ClinicalTrials.gov identifier NCT01966237) was funded by the Thrasher Pediatric Research Foundation and supported by the Center for Acute Care Nephrology, the Heart Institute Research Core, and the Division of Critical Care Medicine at Cincinnati Children\u2019s Hospital Medical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Tomoyuki Mizuno, Katja M. Gist, Zhiqian Gao, Michael F Wempe, Jeffrey Alten, David S. Cooper, Stuart L. Goldstein, and Alexander A. Vinks declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}